Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
we are facing a similar challenge of another drug as an 'insurance policy' but it has possible negative effects and there are no clear paths after a second allogeneic transplant. Part of me is to 'first do no harm' but if it comes back I'll be questioning the decision, the docs are leaving it up to us as there are no stats to go on. We can be in limbo for a few more weeks, tough decision and trying to read, but the science still has not developed enough to sway one decision over another. Which is why they are leaving the decision up to us, they do not know what to do and the guinea pig analogy is quite appropriate.
Hope we make the correct choice!
Edit history
Please sign in to view edit histories.
Recommendations
0 members have recommended this reply (displayed in chronological order):
9 replies
= new reply since forum marked as read
= new reply since forum marked as read